Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schöll

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Brain Connectivity|June 2, 2023
Advances in Alzheimer's DiseaseMichael Schöll
Brain : a Journal of Neurology|December 31, 2019
Does early cognitive decline require the presence of both tau and amyloid-β?Michael Schöll, Anne Maass
JAMA Neurology|May 31, 2017
Linking Amyloid-β and Tau Deposition in Alzheimer DiseasePrashanthi Vemuri, Michael Schöll
PET Clinics|June 9, 2015
Fluorodeoxyglucose PET in Neurology and PsychiatryMichael Schöll, Andrés Damián, Henry Engler
International Journal of Molecular Sciences|July 2, 2021
Tau Seeding Mouse Models with Patient Brain-Derived AggregatesAiko Robert, Michael Schöll, Thomas Vogels
Alzheimer'S Research & Therapy|February 6, 2020
University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019-course organisationAyesha Khatun, Ross W Paterson, Michael Schöll
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2021
Reduced [<sup>18</sup>F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matterAlexis Moscoso, Michel J Grothe, Michael Schöll, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 30, 2026
Cognitive Trajectories from Preclinical Alzheimer's Disease to DementiaFredrik Öhman, Lars Lau Raket, Michael Schöll, et al.
The Journal of Infectious Diseases|November 30, 2023
Reply to FinstererNelly Kanberg, Michael Schöll, Arvid Edén, et al.
Molecular Neurodegeneration|May 9, 2025
Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseasesWongu Youn, Mijin Yun, C Justin Lee, et al.
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Brain Connectivity|June 2, 2023
Advances in Alzheimer's DiseaseMichael Schöll
Brain : a Journal of Neurology|December 31, 2019
Does early cognitive decline require the presence of both tau and amyloid-β?Michael Schöll, Anne Maass
JAMA Neurology|May 31, 2017
Linking Amyloid-β and Tau Deposition in Alzheimer DiseasePrashanthi Vemuri, Michael Schöll
PET Clinics|June 9, 2015
Fluorodeoxyglucose PET in Neurology and PsychiatryMichael Schöll, Andrés Damián, Henry Engler
International Journal of Molecular Sciences|July 2, 2021
Tau Seeding Mouse Models with Patient Brain-Derived AggregatesAiko Robert, Michael Schöll, Thomas Vogels
Alzheimer'S Research & Therapy|February 6, 2020
University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019-course organisationAyesha Khatun, Ross W Paterson, Michael Schöll
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2021
Reduced [<sup>18</sup>F]flortaucipir retention in white matter hyperintensities compared to normal-appearing white matterAlexis Moscoso, Michel J Grothe, Michael Schöll, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 30, 2026
Cognitive Trajectories from Preclinical Alzheimer's Disease to DementiaFredrik Öhman, Lars Lau Raket, Michael Schöll, et al.
The Journal of Infectious Diseases|November 30, 2023
Reply to FinstererNelly Kanberg, Michael Schöll, Arvid Edén, et al.
Molecular Neurodegeneration|May 9, 2025
Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseasesWongu Youn, Mijin Yun, C Justin Lee, et al.
Pageof 19